Core Viewpoint - Theralase Technologies Inc. has successfully closed a non-brokered private placement offering, raising approximately $CAN 1,334,650 to support its clinical study and general corporate purposes [1][2][3]. Group 1: Offering Details - The company issued a total of 7,850,882 Units at a price of $CAN 0.17 per Unit, resulting in gross proceeds of about $CAN 1,334,650 [2]. - Each Unit consists of one common share and one common share purchase warrant, with the warrant allowing the holder to acquire an additional common share at an exercise price of $CAN 0.21 for five years [2]. - A finder's fee of $31,658 was paid, which included $15,470 in cash and $16,188 in common shares, along with the issuance of 186,221 non-transferable finder warrants [4]. Group 2: Use of Proceeds - The proceeds from the financing will be utilized to advance the Phase II Non-Muscle Invasive Bladder Cancer clinical study, as well as for working capital and general corporate purposes [3]. Group 3: Regulatory and Compliance Information - All securities issued under the Offering will be subject to a four-month and one-day hold period, expiring on April 24, 2026, and the Offering is pending final acceptance from the TSX Venture Exchange [6].

Core Viewpoint - Ryder System, Inc. is currently undervalued based on its forward price-to-sales ratio, trading at 0.58X compared to the industry average of 2.29X, indicating an attractive valuation [1][7]. Valuation Metrics - Ryder's forward 12-month price-to-sales ratio is 0.58X, significantly lower than the industry average of 2.29X over the past five years, suggesting a cheap valuation [1][7]. Shareholder Returns - Ryder has consistently paid dividends for over 48 years, with dividend payments of $123 million in 2022, $128 million in 2023, and a projected $456 million in 2024 through dividends and share repurchases [5][6]. - In the first nine months of 2025, Ryder paid $108 million in dividends and repurchased shares worth $350 million, reflecting a commitment to shareholder value [5][6]. Financial Performance - Ryder's stock has increased by 25% over the past six months, outperforming the Zacks Transportation - Equipment and Leasing industry's growth of 10.4% [9]. - The company has raised its free cash flow outlook for 2025 to between $900 million and $1 billion, up from a previous estimate of $375 million to $475 million [8]. Operating Costs and Liquidity - Ryder faces significant financial pressure due to rising operating costs, with total operating expenses increasing from $10.8 billion in 2022 to $11.9 billion in 2024 [12]. - The company's liquidity is concerning, with cash and cash equivalents of $189 million against a current debt level of $577 million, indicating insufficient cash to meet obligations [13]. Earnings Estimates - The Zacks Consensus Estimate for Ryder's earnings has been revised downward for the fourth quarter of 2025 and for full-year 2025 and 2026, reflecting a lack of confidence among brokers [15]. - The current earnings estimates for Q1 2026 have also been projected downward, indicating negative sentiment surrounding the stock [15]. Investment Outlook - Despite attractive valuation and shareholder-friendly initiatives, Ryder faces headwinds from increased operating expenses and a volatile macro environment, making it a risky investment choice at this time [17].

Core Insights - Functional Brands Inc. has launched the Skin, Beauty & Anti-Aging Bundle by Kirkman®, aimed at promoting healthy skin through detoxification, cellular renewal, and protection against environmental stressors [1][6] Product Composition - The bundle includes four key ingredients: Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed Extract, each selected for their clinically supported benefits in skin health and anti-aging [1][6] Ingredient Benefits - **Reduced Glutathione**: Acts as a master antioxidant, neutralizing free radicals and reducing oxidative stress, which contributes to premature skin aging. It supports liver detoxification, enhancing skin clarity and texture [2] - **Zinc Cream**: A topical treatment that soothes irritated skin, promotes wound healing, and supports collagen synthesis. It has antimicrobial and anti-inflammatory properties, effective in reducing acne lesions and improving skin barrier function [3] - **Biotin**: Essential for cellular energy metabolism and keratin production, biotin supplementation improves hair thickness, nail strength, and skin hydration. It has been shown to reduce brittle nails and enhance scalp condition [4] - **Grapefruit Seed Extract**: Provides antioxidant and antimicrobial benefits, protecting skin from environmental toxins. It helps prevent oxidative damage and supports a balanced skin microbiome [5] Availability - The Skin, Beauty & Anti-Aging Bundle by Kirkman® is available for purchase through Kirkman's website and practitioners [6][7]

Core Insights - Ryder System announced a planned CEO succession, with Robert E. Sanchez retiring on March 31, 2026, and John J. Diez being elevated to the CEO position, ensuring leadership continuity and minimizing execution risk [1][2][8] Leadership Transition - John J. Diez, a long-tenured insider with over 20 years at Ryder, will take over as CEO, while Sanchez will remain as executive chair, reinforcing strategic stability and preserving institutional knowledge during the transition [2][4] - Sanchez has been CEO since January 2013 and chairman since May 2013, leaving behind a strong legacy of balanced growth that derisked operations and improved returns [3][8] Strategic Outlook - Diez's appointment is seen as a move towards execution continuity rather than a strategic shift, which strengthens confidence in Ryder System's long-term growth outlook [4][8] - The company has experienced a share price increase of 3.5% over the past 90 days, compared to a 7.2% rise in the Transportation - Equipment and Leasing industry [5]

Core Viewpoint - Ryder System, Inc. has appointed Tammy Romo to its board of directors, effective January 5, 2026, highlighting her extensive experience in financial leadership and governance within the transportation sector [1][2]. Group 1: Appointment Details - Tammy Romo, aged 63, will serve on the Audit and Finance Committees of Ryder's board [1]. - Romo is recognized for her results-oriented leadership style and strategic oversight capabilities in complex public company environments [2]. Group 2: Professional Background - Prior to her appointment, Romo was the executive vice president and chief financial officer of Southwest Airlines, where she managed corporate financial functions for over a decade until her retirement on April 1, 2025 [2]. - With a 30-year tenure at Southwest Airlines, Romo was known for driving transformation and delivering value for the company, which is ranked 156th on the Fortune list [2]. Group 3: Governance Experience - Romo has served as an independent director of Tenet Healthcare Corporation since 2015, further emphasizing her governance expertise [3]. Group 4: Company Overview - Ryder System, Inc. is a fully integrated logistics and transportation company providing a range of services including supply chain solutions, dedicated transportation, and fleet management across more than 20 industries in the U.S., Mexico, and Canada [4]. - The company manages nearly 250,000 commercial vehicles and operates approximately 300 warehouses, totaling over 100 million square feet [4].

Core Insights - Aspire Biopharma Holdings, Inc. has announced professional ultra-marathoner and Ironman champion Ashley Paulson as the official Brand Ambassador for its premier sublingual caffeine product, BUZZ BOMB™ [1] Company Overview - Aspire is recognized as a leader in innovative supplement delivery systems, emphasizing its commitment to product innovation [1] Product Highlight - BUZZ BOMB™ is positioned as a best-in-class product designed to support elite training, recovery, and lifestyle needs of athletes [1] Brand Ambassador Profile - Ashley Paulson is described as a world-class endurance athlete, coach, and inspirational fitness figure, embodying resilience and joy in movement [1]

This story was originally published on Trucking Dive. To receive daily news and insights, subscribe to our free daily Trucking Dive newsletter. Dive Brief: Ryder System has opened a new truck rental and maintenance facility in McDonough, Georgia, as part of its strategy to meet increasing demand in high-growth markets, the company announced in a Dec. 4 press release.  The 20,000-square-foot facility has five drive-through maintenance bays and features RyderGyde, which offers real-time fleet visibility ...

Core Viewpoint - Theralase® Technologies Inc. has initiated a non-brokered private placement to raise up to $CAN 2,000,000 for advancing its clinical studies and working capital needs [1][3]. Group 1: Offering Details - The private placement consists of units priced at $CAN 0.17, each unit includes one common share and one warrant [2]. - Each warrant allows the holder to purchase one common share at an exercise price of $CAN 0.21 for 60 months following the closing date [2]. - The offering is expected to close around the week of December 15, 2025, pending necessary approvals [4]. Group 2: Use of Proceeds - Proceeds from the offering will be utilized to further the Phase II Non-Muscle Invasive Bladder Cancer clinical study and for general working capital [3]. Group 3: Regulatory and Compliance - The offering is available to accredited investors in Canada and U.S. persons under specific exemptions from registration requirements [5]. - All securities issued will be subject to a hold period of four months and one day from the closing date [3]. Group 4: Finder's Fees - The company will pay a finder's fee of 7% of gross proceeds and issue non-transferable finder warrants equal to 7% of the total units issued [6]. Group 5: Company Overview - Theralase® is a clinical stage pharmaceutical company focused on developing light, radiation, sound, and drug-activated therapeutics for treating cancer, bacteria, and viruses [9].

Core Viewpoint - Ryder System, Inc. announced a planned CEO transition, with current CEO Robert E. Sanchez set to retire on March 31, 2026, and John J. Diez named as his successor, which has raised concerns among investors regarding the impact on the company's strategy and continuity [1][2]. Group 1: Leadership Transition - Robert E. Sanchez will step down as CEO effective March 31, 2026, but will continue to serve as executive chair to ensure continuity [1]. - John J. Diez has been appointed as the next CEO, effective the same date, and will also join Ryder's board of directors [2]. - The transition is described as part of a well-planned succession process by the management [2][3]. Group 2: Board and Management Commentary - Michael F. Hilton, Ryder's lead independent director, expressed gratitude for Sanchez's leadership and strategic vision, highlighting the excellent results and record shareholder value achieved during his tenure [3]. - Diez, who currently serves as president and COO, has a strong background with the company, having previously held the role of CFO and led fleet management and dedicated transportation units [4]. - Sanchez expressed confidence in Diez's ability to lead the company, citing their two-decade working relationship and Diez's deep understanding of the business [4]. Group 3: Market Reaction - Following the announcement of the CEO transition, Ryder System shares fell by 2.65%, trading at $192.76 at the time of publication [5].

Core Insights - Ryder System announced a leadership transition with CEO Robert Sanchez retiring at the end of Q1, transitioning to executive chairman, while COO John Diez will take over as CEO [1][5] Company Performance - Under Sanchez's leadership since January 2013, Ryder's annual revenue has doubled to $12.6 billion, and net earnings have increased by 133% to $489 million for the full-year 2024 [3] Leadership Transition - John Diez, who has been with Ryder since 2002 and currently oversees operations across three business segments, is recognized for his deep understanding of the business and strategic mindset, making him well-suited to lead the company [4][5] - The succession plan is described as well-planned, with Diez having an exceptional business track record and a strong grasp of customer needs [5]